Whistler Medical Marijuana Corp (WMMC) today announced that they are the first Licensed Producer of medicinal cannabis in Canada to offer access to their strain genetics through the shipment of live plants. The move builds upon WMMC’s existing organic product range of both dried marijuana and cannabis oils which are already available to eligible patients as part of Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).

Solidifying the company’s position as an industry leader, the expansion will allow patients to share in the substantial research and development invested into producing strong genetics at the companies Coast Mountain facility.


Hand cut from the same mother plants that produce WMMC’s own harvests, each plant shipped will represent three years of careful strain selection, dozens of test grow cycles, and detailed analysis by third party laboratories.

President Chris Pelz comments “True to the Whistler culture of pushing limits, we are thrilled to be the first Licensed Producer to offer some of our genetics to Canadians. We have invested significantly in our Plant Research Program here at WMMC and feel that it is important to share those R & D results to offer increased access to medicinal cannabis for ACMPR registered patients.”

Starting Monday 24th October, eligible ACMPR patients will be able to register with WMMC and purchase plants to produce their own medication. Plants will be shipped via express courier using Clone Shipper, www.cloneshipper.com

To find out more please go to www.wmmc.ca or call +1 604 962 3440.

About Whistler Medical Marijuana Corp.

Operating since 2014, WMMC was one of the first Licensed Producers to be issued a license to operate by Health Canada under the ACMPR (formerly the MMPR). Providing a full spectrum of cannabis products to patients WMMC are Canada’s only 100% organic producer as certified by the Fraser Valley Organic Producers Association. Continuously pioneering progress in medicinal cannabis development, WMMC were also the first producer in Canada to offer their patients access to both THCa and CBG Oils.

Whistler Medical Marijuana Corp.
www.wmmc.ca
+1 604 962 3440

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less